AXA Investment Managers has hired a portfolio manager for its Healthcare fund to strengthen the team following a spate of departures.
AXA Investment Managers is to hand its Health and Biotech funds to Mark Hargraves and Bruno Grandsard on a temporary basis.
Deane Donnigan has resigned from AXA Investment Managers, and will exit the group in June.
Swiss & Global Asset Management has launched the Julian Baer Health Opportunities fund to capitalise on growth potential in the global healthcare sector.
VCT group Albion Ventures has reshaped its sector allocation, tripling environmental holdings and almost doubling healthcare stocks.
BlackRock veteran Bob Doll predicts the US stock market could achieve annualised returns of 8% over the next decade.
The manager of the Finsbury Worldwide Pharmaceutical trust believes companies manufacturing generic medicines will continue to outperform the pharma giants.
Polar Capital has raised £89m for its new Global Healthcare Growth & Income trust.